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Theophylline - discovered in the nineteen thir-
ties - is a measure commonly used in the treatment
of bronchial asthma and other respiratory diseases;
diseases caused by airways obstruction. The
observed effects of theophylline are the result of a
number of biochemical mechanisms such as the
binding towards adenosine receptors, non-selective
inhibition of the various phosphodiesterases (PDE),
increasing the supply of intracellular calcium ions
and indirect effects on different biochemical and
enzymatic pathways (1, 2). Theophylline has a
strong pharmacological effect on central nervous
system (CNS) that causes the improvement of asso-
ciative processes, suppression of fatigue and drowsi-
ness, stimulates the sensory centers, including the
respiratory center. Theophylline works as psycho-
stimulant but its influence is weaker than the influ-
ence of caffeine as penetration of the brain through
the blood-brain barrier is weaker as well.
Theophylline is rapidly and completely absorbed
after oral administration in solution or immediate-
release solid oral dosage form. The estimation of
pharmacokinetic of theophylline shows that nearly
60% is binding to human plasma proteins, primarily
to albumin. Disadvantages of theophylline in the
treatment are of a small range between therapeutic
and toxic dose and the dependence of blood concen-
trations of creatinine clearance. The observed side
effects depend on the concentration of theophylline
in the blood and manifest themselves as headache,
nausea, vomiting, insomnia, cardiac arrhythmia, in
the case of acute poisoning - convulsions and car-
diac arrest (3). Modifications of the structure of
theophylline, which can be seen as a pharma-
cophore, lead to compounds with targeted pharma-
cological effect and/or with improved physicochem-
ical properties, especially solubility, which has a
decisive influence on the pharmacokinetics and
bioavailability. 
Studies carried out on the synthesis and deter-
mination of pharmacological properties of new tri-
cyclic theophylline derivatives, showed that intro-
duction in 7,8-position of theophylline five or six
membered, heterocyclic rings (imidazole or pyrimi-
dine) caused the change of the action profile of these
compounds in the CNS compared to the activity of
the theophylline (4, 5). For instance, derivatives of
imidazo[2,1-f]purine-2,4-dione showed high in vitro
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activity at 5-HT1A receptors and its intrinsic in vivo
activity at this receptor subtype was diversified (6,
7). Preclinical studies indicated that some of com-
pounds exerted anxiolytic-like activity in the four-
plate test on mice and behaved like antidepressants
in the forced swimming test on mice. The results
suggest that tricyclic derivatives of theophylline,
especially with the long chain arylpiperazines
(LCAPs) substituent, remain a worthy and interest-
ing field for future research to obtain new com-
pounds with potential anxiolytic/antidepressant
activity.
In medicinal chemistry numerous measured or
calculated parameters have been used for character-
ization of the lipophilicity but the logarithm of the n-
octanol/water partition coefficient (logP) is still gen-
erally accepted and primarily applied descriptor of
the lipophilicity in quantitative structure-activity
relationships (QSAR) studies. Lipophilicity of drug
candidate can affect both the pharmacokinetic and
pharmacodynamic properties. In particular, the abil-
ity of a molecule to cross the cell membrane
depends on its partition coefficient. Transport across
the blood-brain barrier (BBB) is the most important
feature of new drugs intended to be active in the
central nervous system (8). 
In the paper, we describe the estimation of the
lipophilicity of some LCAPs and tetrahydroiso-
quinoline (THIQ) derivatives with imidazo[2,1-
f]purine-2,4-dione moiety (1-23) (9) by using
reversed-phase high-performance liquid chromatog-
raphy (RP-HPLC) method. It shows that pharmaco-
logical profile of compounds 1-23 can be explained
by different features than theophylline physico-
chemical properties. The relationship between the
concentration of the organic modifier in the mobile
phase and the chromatographic properties of the
investigated compounds; as well as the influence of
substituent on the lipophilicity of compounds, were
studied. Moreover, partition coefficients values
were obtained using software packages. Next step of
investigation was to establish the relationship
between logk0 and theoretically calculated parame-
ters using principal component analysis (PCA)
method. For analysis of pharmacokinetic properties,
the selected absorption, distribution, metabolism or
elimination (ADME) parameters were obtained by
the use of computational methods. The relationships
between logk0 and values of passive diffusion/per-
meability (LogPS), brain penetration (LogBB), pas-
sive absorption (PA%), and plasma protein binding
(PB%) were establish by PCA method.
Table 1. The structures of compounds 1-23.
Comp R R1 n Z Comp R R1 n Z
1 H A 1 H 13 C6H5 A 1 3-Cl
2 H A 1 2-OCH3 14 H A 2 H
3 H A 1 3-Cl 15 H A 2 2-OCH3
4 H A 1 2,3-diCl 16 H A 2 3-Cl
5 H B 1 - 17 H B 2 -
6 CH3 A 1 H 18 CH3 A 2 H
7 CH3 A 1 2-OCH3 19 CH3 A 2 2-OCH3
8 CH3 A 1 3-Cl 20 CH3 A 2 3-Cl
9 CH3 A 1 2,3-diCl 21 CH3 B 2
10 CH3 B 1 - 22 C6H5 A 2 H
11 C6H5 A 1 H 23 C6H5 B 2 -
12 C6H5 A 1 2-OCH3
Reversed-phase high performance liquid chromatography study... 665
EXPERIMENTAL
Materials and methods
Analytical grade chemicals were used, unless
indicated otherwise. Acetonitrile, water (HPLC
grade) and trifluoroacetic acid (TFA) were supplied
by Merck (Darmstad, Germany). Water was deion-
ized by use of a Milipore system. The investigated
LCAPs and THIQ derivatives of imidazo[2,1-
f]purine-2,4-dione were synthesized according to
the methods described in the literature (6, 7). The
chemical structures of these compounds are present-
ed in Table 1.
Chromatography
RP-HPLC analysis was performed on a Waters
Alliance HPLC instrument with Waters 2695
Separation Module with photodiode array detector
Waters 2998, absorbance was measured at wave-
length 230 nm. Separation was performed on a C18
HPLC column (LiChrospher 100 R, 100 ◊ 4.6 mm,
5 µm, Merck) fitted with a C18 guard column. A con-
stant flow rate of 1 mL/min was used, the injection
volume was 10 µL. Mobile phase A consisted of
0.01% trifluoroacetic acid (TFA) in water and
mobile phase B consisted of 0.01% TFA in acetoni-
trile. Elution was isocratic with acetonitrile content
between 65% and 35% (v/v) in 5% increments. The
compounds were dissolved in methanol (0.5
mg/mL) and 10 µL solutions were separately inject-
ed on the column. The dead time was measured by
injection of methanol. The retention times (tr) and
dead times (t0) were the means of three independent
determinations. 
The isocratic capacity factors logk, were calcu-
lated from the experimental, retention times (tr) and
dead time (t0) according to Eq. (1): 
logk = log[(tr - t0)/t0] (1)
The log k values were extrapolated to zero acetoni-
trile concentration by use of equation 2:
logk = logk0 - SΦ (2)
where, Φ is the concentration of acetonitrile in the
mobile phase [v/v].
Calculations 
The coefficients AlogPs, milogP, logPKOWIN and
XlogP2 were calculated from the Virtual
Computational Laboratory website (10), logPPallas by
Pallas 3.1 and XlogP by CAChe 7.75. ADME prop-
erties were prepared with ACD/Percepta trial ver-
sion Build 2254 software. The SMILES codes were
drawn in ACD/Labs.
Bartlettís test was performed, which verifies
the null hypothesis that the correlation matrix is the
identity matrix (coefficients between variables are
zero). The coefficient of Kaiser-Mayer-Olkin
(KMO) was also calculated, to verify the degree of
correlation of the original variables. Before PCA has
Figure 1. The dependence between log k values and concentration of acetonitrile in mobile phase for compound 12
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been started, were evaluated the merits of its appli-
cation. The resulting value of the statistics U Bartlet
was 145.5 and the associated level of p < 0.000001,
could rejected the null hypothesis. The resulting
ratio for coefficient of KMO test was more than the
average - 0.65. It was concluded that there was suf-
ficient grounds for the use of principal components
analysis (11).
All graphs and regression analysis was per-
formed with the Statistica program (Statistica ver-
sion 10.0, StatSoft Inc., 2011). The significance
level of performed calculations was above 95%.
RESULTS
The retention factors logk of the compounds
decreased linearly with increasing concentration of
acetonitrile in the mobile phase. The obtained
results enabled calculation of polycratic logk0 values
with equation (2). The dependence of the logk value
on the concentration of acetonitrile for compound 12
is presented in Figure 1. The relative lipophilicity,
expressed as logk0 values and parameters obtained
from the regression analysis, such as the correlation
coefficients (r), the standard errors of estimation (s)
and values of F-test of significance (F), are listed in
Table 2. The significance level of performed calcu-
lation was p ≤ 0.05
The linear correlation between the volume
fraction of acetonitrile and the logk values was
established with moderately low values of correla-
tion coefficients (0.9072 < r < 0.9785) for com-
pounds 1, 2, 3, 5, 10, 15, 21, 23 and high for other (r
> 0.9815). The relative lipophilicity of the investi-
gated compounds (1-23) was low, the lowest for
compound 5 (logk0 = 0.217) and the highest for
compound 13 (logk0 = 1.339). The logk0 values were
also compared with the theoretical values of parti-
tion coefficients (Table 3). Noteworthy there is the
large difference between the values set calculated by
the computer programs and obtained experimental-
Table 2. Data for linear correlation (equation 2) between logk values and the concentration of acetonitrile [C (%, v/v)] in the mobile phase
for compound 1-23.
Compound logk0 r s F n Compound logk0 r s F n
1 0.485 0.9106 0.0986 20 7 13 1.339 0.9718 0.0401 105 6
2 0.597 0.9354 0.0736 20 6 14 0.475 0.9624 0.0281 128 7
3 0.697 0.9371 0.0425 59 6 15 0.513 0.9251 0.0218 69 6
4 0.876 0.9869 0.0614 31 6 16 0.529 0.9577 0.0327 90 6
5 0.217 0.9412 0.0114 45 7 17 0.260 0.9611 0.0168 24 6
6 0.266 0.9815 0.0370 17 7 18 0.716 0.9860 0.0243 280 6
7 0.271 0.9950 0.0517 34 7 19 0.687 0.9764 0.0309 165 6
8 0.708 0.9642 0.0309 107 7 20 0.787 0.9785 0.0245 182 6
9 0.312 0.9686 0.0079 62 5 21 0.492 0.9279 0.0181 64 7
10 0.370 0.9072 0.0614 20 7 22 0.733 0.9868 0.0581 72 6
11 0.715 0.9764 0.0268 206 7 23 0.707 0.9450 0.0186 85 7
12 1.140 0.9971 0.0005 135 6 Theophylline -0.95 0.9529 0.0491 87 6
Correlation coefficient (r), the standard error of estimation (s) and value of F-test of significance (F), n - number of data points.
Figure 2. Comparison of the logk0 and calculated coefficients by
PCA. 1 - AlogPs; 2 - milogP; 3 - logPKOWIN; 4 - XlogP2; 5 -
logPPallas; 6 - logPCAChe; 7 - logk0. Vector log k0 lies in the second
quarter, shows a positive correlation with the third component, a
negative correlation with the first component. It also has the high-
est values of the vector coordinates of the end as high (about 0.7)
for the first and third component
Reversed-phase high performance liquid chromatography study... 667
ly. For example, values of logP obtained for com-
pounds 13 were 4.13, 9.93, 5.06, 4.45, 3.67 and
3.48, respectively.
The multivariate comparison of the experimen-
tally obtained values and the coefficients calculated
by the computational methods was made by PCA.
PCA searches for a few uncorrelated linear combi-
nations of the original variables that capture most of
the information in the original variables. The graph-
ical interpretation of the multidimensional space of
the data set used by the PCA transformation is
obtained with a smaller number of new dimensions
of space. The number of principal components (PC)
was selected using the criterion of Kaiser.
Considering the above eigenvalues and proportions
of explained variance it would be reasonable to
investigate first two components, which explained
more than 78.89% of the variability of the data set.
The PC1 is determined by AlogPs, milogP,
logPKOWIN, XlogP2 and logPPallas, when PC2 is deter-
mined by XlogPCAChe and logPPallas. 2D-dimensional
projection (Fig. 2) shows that all of original vari-
ables are strongly associated with their constituents
and negatively correlated with PC1. Moreover, vari-
ables logk0 is not well explained by PC1 and PC2. 
The next part of our study was to establish the
nature of relationship between selected ADME
parameters and log k0. The absorption process was
characterized by protein bound (PB%) and passive
absorption (PA%) parameters. The lowest values of
PB% were calculated for compounds 5 and 17
(59.24%, 58.58%, respectively) with THIQ moiety
and were similar to theophylline. For the rest of com-
pounds PB% was much higher, from approximately
60 to 95 percent. For all compounds the percent of
passive absorption is very high and has the same
value (100%). For determinant of brain barrier pene-
tration the values of automatically calculated param-
eters of rate of brain penetration (LogPS) and extent
of brain penetration (LogBB) were taken. For all
compounds values of LogPS were in the range of -
2.2 to -1.3 and were higher than for theophylline (-
Table 3. Six logP values obtained by the use of computational methods.
Compound AlogPs MlogP logPKOWIN XlogP2 logPPALLAS logPCAChe
1 2.16 2.12 2.65 2.02 1.50 1.96
2 2.41 2.11 2.71 1.91 1.57 1.70
3 2.95 2.97 1.29 2.64 2.24 2.48
4 2.01 2.12 2.85 1.76 0.77 1.76
5 2.71 2.54 1.20 2.48 0.99 1.52
6 2.80 2.55 1.28 2.19 1.05 1.27
7 1.26 1.19 1.84 1.10 1.71 2.04
8 2.41 2.14 2.40 2.22 1.28 1.11
9 1.65 1.99 4.41 1.81 2.91 2.96
10 1.65 4.0 4.49 1.75 1.00 2.71
11 4.11 4.64 5.06 4.45 1.67 1.48
12 3.65 3.20 4.49 3.75 3.00 2.71
13 4.13 3.93 5.06 4.45 3.67 3.48
14 2.82 2.67 3.14 2.38 2.02 2.41
15 2.81 2.42 3.22 2.29 2.09 2.16
16 3.33 3.15 3.78 3.00 2.76 2.93
17 3.09 3.19 4.48 2.94 1.28 2.21
18 3.15 2.88 3.69 2.84 1.50 1.97
19 3.20 2.63 3.77 2.75 1.57 1.72
20 3.66 4.33 3.46 3.46 2.24 2.49
21 3.63 3.41 5.03 3.40 1.80 1.78
22 3.95 3.93 4.90 4.19 3.45 3.41
23 4.68 4.48 6.25 4.75 2.23 3.21
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2.7). Moreover, contrary to theophylline, for all com-
pounds the LogBB parameter is positive (Table 4).
Results of simulations for compounds 1-23
suggest the possibility of good their brain - plasma
penetration. The PCA analysis showed that the two
principal components (PC1, PC2) explain 90.79% of
the total variance (Fig. 3). The PC1 is determined by
logk0, PB%, LogP, logPS and those variables had
been strongly interlinked and constituted a homoge-
neous group. The second component represents the
only variable LogBB. All variables are strongly
associated with their constituents. The first compo-
nent is negatively (-0.73; -0.92; -0.95; -0.96) corre-
lated with variables logk0, PB%, LogP, logPS.
DISCUSSION AND CONCLUSION
Having analyzed the impact of chemical struc-
ture on the relative lipophilicity, it was found that it
depends on three chemical factors: firstly, the length
of alkylene chain linking the nitrogen atom of the
tricyclic system with nitrogen atom of the arylpiper-
azine group; secondly, the presence and type of sub-
stituent in the LCAP system or replacement LCAP
with THIQ moiety and thirdly, type of substituent at
the 7-position of the imidazo[2,1-f] theophylline.
The analyses revealed that the length of the alkylene
chain, connecting the nitrogen atom N8 of the tri-
cyclic secondary amine nitrogen atom, had no sig-
nificant effect on the value of the relative lipophilic-
ity for the compounds. Logk0 were in the range of
0.217 to 1.339 for compounds with three methylene
unit spacer between imidazo[2,1-f] theophylline and
arylpiperazinyl moiety. Unexpectedly, for their
analogs with four carbon chain, obtained logk0 val-
ues were in the similar range (0.226-0.787). There
was no significant effect of the type of substituent in
phenyl ring in LCAP fragment on the relative value
of lipophilicity but the number of substituents (e.g.,
comp. 2 vs. 3 and comp. 3 vs. 4) and replacement
LCAP with THIQ were significant (e.g., comp. 1 vs.
5). Derivatives of THIQ demonstrated the lowest
values of logk0 (comp. 5, 10, 17, 21) with one excep-
tion of compound 23. The greatest impact on
lipophilicity seems to have a substituent at the 7-
position of the imidazo[2,1-f] theophylline.
Compounds 13 and 22 (derivatives of LCAP and
THIQ, respectively) with the highest relative
lipophilicity, contain phenyl ring at 7-position of
imidazo[2,1-f]theophylline. This trend was mani-
Table 4. The selected ADME values.
Comp LogPS LogBB PB % PA % log k0 Comp LogPS LogBB PB % PA % log k0
1 -2.1 0.27 62.70 100 0.485 13 -1.3 0.63 95.49 100 1.339
2 -2.2 0.21 64.65 100 0.597 14 -2.0 0.41 65.91 100 0.475
3 -1.7 0.50 77.30 100 0.697 15 -2.2 0.38 62.89 100 0.513
4 -1.5 0.45 87.85 100 0.876 16 -1.7 0.64 77.75 100 0.529
5 -2.1 0.50 59.24 100 0.217 17 -2.0 0.72 58.58 100 0.226
6 -2.0 0.36 68.12 100 0.266 18 -1.9 0.51 68.15 100 0.716
7 -2.1 0.35 65.24 100 0.271 19 -2.0 0.53 65.49 100 0.687
8 -1.6 0.59 80.50 100 0.708 20 -1.5 0.85 81.09 100 0.787
9 -1.4 0.67 88.39 100 0.312 21 -1.8 0.90 60.82 100 0.492
10 -2.0 0.67 61.30 100 0.370 22 -1.5 0.54 93.04 100 0.733
11 -1.5 0.47 91.31 100 0.715 23 -1.5 0.94 90.28 100 0.707
12 -1.6 0.49 90.21 100 1.140 Theophylline -2.7 -0.04 60.64 100 0.950
Figure 3. Comparison of the logk0 and ADME parameters by PCA
1 - logk0; 2 - PB%; 3 - LogBB; 4 - LogPS
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fested strongly in the group of THIQ derivatives,
where compound 23 with phenyl ring at 7-position
of annelated theophylline demonstrated two times
higher logk0 value than their analogue with methyl
group. The most of the available computer algo-
rithms for calculation of logP do not recognize well
enough new created system, based on the fusion of
an additional ring (imidazole) to an already existing
one (theophylline). It can be assumed that the results
of the rings junction - cyclic guanidine group - sig-
nificantly alters the properties of the imidazo[2,1-
f]theophylline. The significant differences between
logk0 and theoretical values (AlogPs, milogP,
logPKOWIN, XlogP2 and logPPallas) were the reasons for
seeking statistical methods that allow an appropriate
way to present relationships between logk0 and are
obtained by use of computational algorithms. PCA
analysis showed that none of the computers algo-
rithm gives high correlation with experimental data.
The results of ADME assay were compared to
experimental logk0 values by PCA technique and it
has showed a high correlation between logk0 and
brain barrier penetration. Moreover, those studies
indicate that for the THIQ derivatives of imida-
zo[2,1-f] theophylline values of logk0 were lower
than for LCAPs analogs. So far, THIQ was treated
as isostere, with comparable to 1-arylpiperazine
moiety physicochemical properties (12) but
deprived of receptor 5-HT1A activity. 
Summing up, the present study described a
simple method for determination of lipophilicity
parameters by RP-HPLC of a model series of tri-
cyclic theophylline derivatives. The results above,
confirm the legitimacy of the determination of
lipophilicity for the investigated compounds by the
use of the experimental method. The RP-HPLC
technique can be regarded as the better one for the
determination of the lipophilicity of tricyclic theo-
phylline derivatives than the computational proce-
dures. 
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